Back to Rankings

MRNA

ModernaD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
MRNA vs peer average
31/100
MRNA vs. peer average (D vs. C)
Grade spread
A 3 · B 2 · C 2 · D 2 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

IONS is the first available peer comparator.

Ionis is another mid-cap R&D-heavy biotech comparison; despite a different modality, it underscores how investors focus on late-stage cadence and cash-runway visibility when commercial diversification is still incomplete.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerIONSIonis
MRNA
Moderna
IONS
Ionis
Grade
D
C
Momentum
45
47
Value
41
41
Sentiment
46
69
Setup Bias
Net Bullish
-
Market Cap
-
-
Posture
Defensive
Mixed

Grade position vs IONS

MRNA / IONS
Grade Position
Below peers
MRNA vs. peer average (D vs. C)
31/100
Momentum
45
IONS
Value
41
MRNA
Sentiment
46
IONS

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs MRNA
1
IONS
IONS
C
60/100
-1
2
MDGL
MDGL
F
20/100
+1
3
ASND
ASND
F
20/100
+1
4
VTRS
Viatris Inc Common
A
100/100
-3
5
INCY
Incyte Corp Common
B
80/100
-2
IONS is the first peer returned for this comparison set.